CA
HQL
Cornerstone Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,339
| Closed | -$317K | – | 299 |
|
|
2024
Q2 | $317K | Sell |
22,339
-9,575
| -30% | -$136K | 0.01% | 283 |
|
|
2024
Q1 | $435K | Sell |
31,914
-462,426
| -94% | -$6.3M | 0.02% | 293 |
|
|
2023
Q4 | $6.65M | Buy |
494,340
+209,708
| +74% | +$2.82M | 0.29% | 86 |
|
|
2023
Q3 | $3.55M | Buy |
284,632
+27,333
| +11% | +$341K | 0.17% | 149 |
|
|
2023
Q2 | $3.48M | Buy |
257,299
+5,109
| +2% | +$69.2K | 0.17% | 144 |
|
|
2023
Q1 | $3.51M | Buy |
252,190
+1,700
| +0.7% | +$23.7K | 0.16% | 123 |
|
|
2022
Q4 | $3.56M | Buy |
250,490
+72,000
| +40% | +$1.02M | 0.18% | 126 |
|
|
2022
Q3 | $2.44M | Buy |
178,490
+164,990
| +1,222% | +$2.25M | 0.12% | 151 |
|
|
2022
Q2 | $192K | Buy |
+13,500
| New | +$192K | 0.01% | 188 |
|
|
2020
Q1 | – | Sell |
-175,073
| Closed | -$3.05M | – | 194 |
|
|
2019
Q4 | $3.05M | Buy |
+175,073
| New | +$3.05M | 0.25% | 107 |
|
|
2019
Q1 | $360K | Buy |
21,000
+5,000
| +31% | +$85.7K | 0.03% | 183 |
|
|
2018
Q4 | $242K | Buy |
+16,000
| New | +$242K | 0.02% | 218 |
|